Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Effect of silymarin in diabetes mellitus patients with liver diseases

    Manonmani Alvin Jose1★, Anjana Abraham2, M. P. Narmadha2★ Corresponding author

    1. 1Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Tamil Nadu, India.
    2. 2Pharmacy Practice, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Tamil Nadu, India.

    CORRESPONDENCE

    Manonmani Alvin Jose

    Department of Pharmacology, Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Tamil Nadu, India.

    Pharmjose@gmail.com

    Volume 2, Issue 4 · pp. 287–289 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.85950

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    The liver is involved in the maintenance of homeostasis within the body. Other functions of the liver include protein synthesis, storage and metabolism of fats and carbohydrates, detoxification and excretion of drug and other toxins. Diabetes developed as a complication of cirrhosis is known as hepatogenous diabetes. Around 30–60% of cirrhotic patients suffer from this metabolic disorder. There is a high prevalence of metabolic syndrome, obesity, and type 2 diabetes mellitus with cryptogenic cirrhosis. Several reports have claimed a specific association between hepatitis C virus (HCV) infection and type 2 diabetes, but in most instances patients were a mixture of cases with cirrhosis, hepatitis and diabetes. Silymarin is a hepatoprotective drug obtained from Silibum marium. Silymarin is reported to have different properties like hepatoprotective activity, anti-inflammatory activity, antioxidant activity, and anti-cancer activity. Previous reports of both pre-clinical and clinical studies revealed that silymarin has got some anti-diabetic potential. Considering all the above reports and keeping the evidences in mind, this study was undertaken with the objective to assess the effect of silymarin in diabetes mellitus patients with hepatic diseases.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Jose, M. A., Abraham, A., & Narmadha, M. P. (2011). Effect of silymarin in diabetes mellitus patients with liver diseases. Journal of Pharmacology and Pharmacotherapeutics, 2(4), 287–289. https://doi.org/10.4103/0976-500X.85950